Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer—Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT

The purpose of this study was to evaluate the outcome after Radium-223-dichloride ((223)RaCl(2)) treatment of patients with skeletal metastases of castration resistant prostate cancer using whole-body (18)F-Fluoride PET/CT. Sodium (18)F-fluoride [(18)F]-NaF PET/CT was performed prior the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kairemo, Kalevi, Joensuu, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728467/
https://www.ncbi.nlm.nih.gov/pubmed/26854163
http://dx.doi.org/10.3390/diagnostics5040413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728467/
https://www.ncbi.nlm.nih.gov/pubmed/26854163
http://dx.doi.org/10.3390/diagnostics5040413

Ejemplares similares